News of the WeekAids

European Vaccine Effort Faces Chinese Puzzle

Science  05 Nov 1999:
Vol. 286, Issue 5442, pp. 1062-1063
DOI: 10.1126/science.286.5442.1062

You are currently viewing the summary.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


Summary

PARIS-- During an international AIDS meeting here last week, a group of researchers quietly met to plan a 3-year, $9.2 million European Union (EU)-backed effort to develop an AIDS vaccine. The new initiative, called EuroVac, is expected to begin on 1 January and will mark the first time the EU has attempted to pull Europe's top AIDS researchers together into a unified vaccine drive. Yet though the contracts between the EU and the researchers are still being negotiated, the initiative has already become tangled in international AIDS vaccine politics.

Related Content